Semax vs Selank

These two molecules sit in the same general bucket — Russian-origin neuropeptide analogs developed in Soviet-era research labs and used clinically in Russia for stroke recovery and anxiety respectively — but the parent sequences are completely different. Semax is derived from a fragment of ACTH(4-10); selank is derived from tuftsin, a tetrapeptide fragment of an immunoglobulin heavy chain. The shared label of nootropic peptide hides genuinely different chemistry.

Observed effect profile in logs reflects that chemistry difference. Semax logs tend to emphasize cognitive endpoints — focus, working-memory feel, and the cleaner verbal-fluency signal the published Russian work centers on. Selank logs tend to emphasize anxiolytic and mood endpoints, with the published evidence base built around generalized anxiety rather than acute cognitive performance. Neither molecule is approved outside Russia, and the human evidence base is much thinner than the marketing volume on either suggests.

Administration is unusual for both — intranasal is the standard route in the published Russian work and the most common route in research-peptide logs as well, with subcutaneous as a less-common alternative. Per-dose milligrams are in the same general range (typically 250–1000 mcg per administration for either). The vial math on either molecule reconstituted at the same concentration produces similar unit counts on a 100-unit syringe; the calculator pages linked below handle the conversion.

Cadence is daily for both, often multi-administration during a cycle and then off for a similar period. The two molecules can be logged in parallel without much workflow conflict because they target different self-reported endpoints — a stacked semax-and-selank log usually has one cognitive-feel field and one anxiety-feel field, with administration timestamps for each molecule rather than a merged event timeline.

For the Semax vs Selank decision specifically, the calendar shape is what most readers underweight. Semax's example vial is 5 mg drawn against 0.4 mg per dose at 7 doses per week. Selank's example vial is 5 mg drawn against 0.3 mg per dose at 7 doses per week. Those four numbers feed every column in the table above; change any one and the semax vs selank comparison shifts with it.

Concentration in this pair: Semax sits at 2.50 mg/mL on the example reconstitution; Selank sits at 2.50 mg/mL on its example. That single ratio is what determines how many U-100 syringe units a given dose of either molecule actually draws, so it is the first thing to confirm before treating any "Semax vs Selank" unit number on the internet as authoritative.

Doses per vial in this matchup work out to roughly 12 for Semax and 16 for Selank at the example dose sizes, with vial-duration windows near 1.7 weeks and 2.3 weeks respectively. Refill cadence follows directly from those windows, which is why the semax vs selank pair shows up in planning conversations more than in pure mechanism conversations.

When readers compare Semax against Selank, the Semax-side mistakes that show up most in logs are: Using the peptide continuously for months without taking any breaks. Storing the reconstituted vial at room temperature instead of in the refrigerator. Shaking the vial vigorously during reconstitution, which can damage the peptide. Starting with a very high dose instead of titrating up from a lower one. Each of these gets amplified when a reader is also actively comparing against Selank, because muscle memory from one molecule's unit math leaks into the other.

Semax question worth answering up front — What's the difference between Semax and Selank? Both are well-known Russian peptides, but they are studied for different primary purposes. Semax is primarily researched for its cognitive and neurotrophic effects, focusing on things like memory, focus, and brain repair. Selank, on the other hand, is mainly studied for its anti-anxiety (anxiolytic) properties, helping to reduce stress and stabilize mood.

Semax question worth answering up front — Why is Semax often available as a nasal spray? The nasal passages contain a rich blood supply and a direct pathway to the brain, partly bypassing what is known as the blood-brain barrier. For certain molecules like Semax, this intranasal route can allow for very rapid absorption and onset of action in the central nervous system. Many users prefer this method for its convenience and speed, although injectable forms allow for more precise dosing.

On the Selank side of the Semax vs Selank decision, the recurring mistakes are: Using tap water or sterile water instead of bacteriostatic water for reconstitution. Shaking the vial vigorously after adding water, which can damage the peptide. Assuming its effects will be as immediate or intense as a stimulant. Inconsistent dosing, such as skipping days during an "on" cycle. These are not generic dosing slips — they are the ones that compound when Selank is being logged in parallel with Semax.

Selank question worth answering up front — What is the difference between Selank and Semax? Selank and Semax were developed by the same Russian institution and are both peptide-based nasal sprays, but they are used for different primary purposes. Selank is generally explored for its anti-anxiety (anxiolytic) effects, while Semax is more known for its cognitive-enhancing (nootropic) and neuroprotective qualities. While there's some overlap, people typically turn to Selank for calm and mood support, and to Semax for focus, memory, and stimulation.

Selank question worth answering up front — Why is Selank usually administered as a nasal spray? The intranasal route is common for Selank because it allows the peptide to be absorbed through the nasal mucosa and gain rapid access to the brain. This method bypasses the digestive system, where the peptide would be broken down, and avoids the first-pass metabolism in the liver. This is thought to lead to higher bioavailability in the brain compared to oral ingestion.